Skip to main content

Table 5 Immunohistochemical characteristics

From: Novel clinicopathological and molecular characterization of metanephric adenoma: a study of 28 cases

Patient Number BRAF status CK7 AMACR WT-1 CD57 P53 BCL2 CCND1 P16 p-ERK ERK p-MEK MEK DUSP6
1 BRAF V600E 3+ 2+ 3+ 3+ 3+ 2+ 3+ 2+
2 BRAF wild-type 3+ 3+ 2+ 3+ 2+ 3+ 1+
3 BRAF V600E 1+ 2+ 1+ 2+ 1+ 2+ 1+
4 BRAF wild-type 2+ 2+ 1+ 2+ 1+ 3+
5 BRAF V600E 3+ 3+ 1+ 3+ 2+ 3+ 1+
6 BRAF V600E 3+ 2+ 1+ 2+ 1+ 2+ 1+
7 BRAF V600E 1+ 2+ 2+ 2+ 1+ 1+ 1+ 2+ 1+
8 BRAF V600E 2+ 2+ 2+ 2+ 2+ 1+ 3+
9 BRAF V600E 3+ 3+ 3+ 2+ 1+ 2+ 1+ 3+ 1+
10 BRAF V600E 1+ 3+ 2+ 2+ 1+ 1+ 1+ 3+ 2+
11 BRAF V600E 3+ 2+ 3+ 3+ 1+ 2+ 1+ 2+ 2+
12 BRAF V600E 3+ 3+ 3+ 2+ 2+ 1+ 2+
13 BRAF V600E 2+ 3+ 2+ 1+ 1+ 1+ 2+ 1+
14 BRAF V600E 3+ 2+   2+ 1+ 1+ 1+ 1+ 2+ 1+
15 BRAF V600E 1+ 3+ 1+ 2+ 2+ 1+ 2+
16 BRAF V600E 1+ 1+ 2+ 1+ 1+ 2+ 3+
17 BRAF wild-type 1+ 1+ 1+ 2+ 1+ 3+ 1+
18 BRAF V600E 1+ 1+ 3+ 3+ 3+ 1+ 3+ 1+
19 BRAF V600E 1+ 3+ 2+ 3+ 1+ 1+ 2+
20 BRAF Intron8-STARD9/ CUX1/ LOC100507389 fusion +/− 1+ 1+ 3+ 3+ 1+ 2+ 1+ 2+ 1+
21 BRAF V600E 1+ 1+ 2+ 1+ 1+ 1+ 3+ 1+
22 BRAF V600E 1+ 1+ 3+ 1+ 1 1+ 1+ 2+ 1+
23 BRAF V600E +/− 1+ 1+ 1+ 3+ 2+ 1 1+ 1+ 2+ 1+
24 BRAF wild-type 1+ 1+ 2+ 1+ 2+ 1+ 1+ 1+
25 BRAF wild-type 1+ 1+ 3+ 1+ 3+ 2+ 2+
26 BRAF V600E 1+ 1+ 3+ 1+ 3+ 1+ 3+ 2+
27 BRAF V600E 1+ 1+ 2+ 2+ 1+ 1+ 3+ 1+
28 BRAF V600E 1+ 1+ 3+ 1+ 1+ 1+ 1+ 1+ 1+